欧林生物陷合同纠纷，部分账户被冻结

Core Viewpoint - Chengdu Olin Biotechnology Co., Ltd. (688319.SH) is facing a lawsuit from Wang Jianhua, who claims a total of 16 million yuan in commission for vaccine products and an additional 3.2 million yuan in penalties, which the company disputes as lacking factual and legal basis [1] Group 1: Legal Proceedings - The company received a notice from the Chengdu Intermediate People's Court regarding the lawsuit filed by Wang Jianhua [1] - Wang Jianhua asserts that he has fulfilled his obligations under a contract signed in 2011, which entitles him to claim commissions [1] - The company plans to actively respond to the lawsuit and does not recognize the claims made by the plaintiff [1] Group 2: Financial Impact - As a result of the lawsuit, some of the company's bank accounts have been frozen, with 19.2 million yuan frozen, which represents 2.06% of the company's latest audited net assets attributable to shareholders and 8.57% of its cash balance [1] - The company stated that the account freeze will not have a significant impact on its daily operations [1]